Aurora Cannabis - Common Shares (ACB) closed at $5.19 on November 5, 2026, down 1.0% from the previous close, on volume of 5,056,511 shares (30-day average 1,301,303).
Data as of November 5, 2026.
Aurora Cannabis Files September 2026 Interim Financial Statements
TipRanks (Thu, 5-Nov 8:14 AM ET)
Aurora Cannabis Reports Fiscal Second-Quarter Results Amid Organigram Acquisition Agreement
TipRanks (Thu, 5-Nov 8:13 AM ET)
Aurora Cannabis Announces Fiscal 2027 Second Quarter Results
Business Wire (Thu, 5-Nov 7:05 AM ET)
Curaleaf Issues Statement Regarding Alternative Proposal for Aurora Cannabis
PRNewswire (Tue, 3-Nov 5:45 PM ET)
Market Chameleon (Tue, 3-Nov 5:24 AM ET)
Organigram to buy Aurora Cannabis amid hostile bid from Curaleaf
Seeking Alpha News (Tue, 3-Nov 10:02 AM ET)
Organigram Agrees to Acquire Aurora for C$561 Million
TipRanks (Tue, 3-Nov 9:54 AM ET)
Organigram to Acquire Aurora and Establish a Global Cannabis Leader
Business Wire (Tue, 3-Nov 9:16 AM ET)
Aurora Cannabis to Host Second Quarter 2027 Investor Conference Call
Business Wire (Thu, 29-Oct 7:00 AM ET)
Aurora Cannabis Inc is focused on the production, distribution, and sale of cannabis products in Canada and internationally. The Company conducts the production, distribution, and sale of medical cannabis products and, on a very limited basis, consumer cannabis products in Canada pursuant to the Cannabis Act; the production and distribution of wholesale medical cannabis in the European Union pursuant to the German Medicinal Products Act and German Narcotic Drugs Act; and the distribution of wholesale medical cannabis in various international markets, including Australia and New Zealand. Its segments are Canadian Cannabis CGU, European Cannabis CGU, Australia Cannabis CGU, and New Zealand Cannabis CGU, with Canada generating majority revenue.
Aurora Cannabis - Common Shares trades on the NASDAQ stock market under the symbol ACB.
As of November 6, 2026, ACB stock price was flat at $5.19 with 1,282,178 million shares trading.
ACB has a beta of 1.53, meaning it tends to be more sensitive to market movements. ACB has a correlation of 0.12 to the broad based SPY ETF.
ACB has a market cap of $321.48 million. This is considered a Small Cap stock.
Last quarter Aurora Cannabis - Common Shares reported $61 million in Revenue and -$.22 earnings per share. This beat revenue expectation by $9 million and missed earnings estimates by -$.19.
In the last 3 years, ACB traded as high as $9.35 and as low as $2.56.
The top ETF exchange traded funds that ACB belongs to (by Net Assets): MJ, YOLO, DFIC.
ACB has outperformed the market in the last year with a price return of +16.4% while the SPY ETF gained +10.1%. ACB has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +78.4% and +30.7%, respectively, while the SPY returned -3.8% and -3.3%, respectively.
ACB support price is $5.02 and resistance is $5.36 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ACB shares will trade within this expected range on the day.
